Bevacizumab Dramatically Improves Severe Hereditary Hemorrhagic Telangiectasia (HHT) Associated Blee (IMAGE)

Elsevier

Bevacizumab Dramatically Improves Severe Hereditary Hemorrhagic Telangiectasia (HHT) Associated Blee

Caption

Improved mucocutaneous telangiectasias after intravenous bevacizumab treatment.

Credit

Mayo Clinic Proceedings

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.